Portfolio Company RoosterBio Highlighted in Dynamk’s Recent Annual General Meeting Dynamk Capital November 1, 2021
Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis Pharma’s Almanac September 29, 2021
RoosterBio Releases RoosterGEM™, Cell and Gene Therapy’s First Complete Transduction Medium BioInformant May 21, 2021
Rooster Bio and Sartorius Team to Streamline hMSC Production BioProcess International January 22, 2021
RoosterBio Battles COVID-19 with Innovative Bioprocess Manufacturing Strategies RMI of Maryland October 12, 2020
Sentien Biotechnologies-Led Team Awarded $2.4M Contract from the U.S. Department of Defense and the Medical Technology Enterprise Consortium PRWEB October 8, 2020
